esophageal and head and neck cancers
Conditions
Interventions
None listed
Sponsors
Division of Esophageal Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Esophageal cancer: Patients with lesions mainly located in the cervical and thoracic esophagus and gastroesophageal junction. Histological type is not specified. Head and neck cancer: Patients with lesions mainly located in the larynx and middle and lower pharynx. Histological type is limited to squamous cell carcinoma.
Exclusion criteria
Exclusion criteria: Head and neck cancer: Patients with lesions mainly located in the lips and oral cavity, nasal cavity and paranasal sinuses, major salivary glands, and nasopharynx. Also, patients with non-squamous cell carcinoma of the larynx and middle and lower pharynx.Cases that refused participation by opting out
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year overall survival rate | — |
Secondary
| Measure | Time frame |
|---|---|
| 5-year recurrence-free survival rate, treatment-related adverse events (surgery, chemotherapy, radiation therapy), cause of death (esophageal cancer, head and neck cancer, death from other cancers, death from other diseases) | — |
Countries
Japan
Contacts
Public ContactJun Kanamori
Division of Esophageal Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Rese Division of Esophageal Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Rese
Outcome results
None listed